Pfizer
PFE
PFE
1,886 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 694 increasing their positions, 840 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $155B → $146B (-$8.75B)
12% less funds holding in top 10
Funds holding in top 10: 310 → 272 (-38)
17% less repeat investments, than reductions
Existing positions increased: 694 | Existing positions reduced: 840
Holders
1,886
Holding in Top 10
272
Calls
$1.89B
Puts
$1.36B
Top Buyers
| 1 | +$635M | |
| 2 | +$510M | |
| 3 | +$461M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$267M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$205M |
Top Sellers
| 1 | -$895M | |
| 2 | -$552M | |
| 3 | -$435M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$405M |
| 5 |
IC
Institutional Capital
Chicago,
Illinois
|
-$371M |